Suspected Kidney Stone: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (6 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
===5.18 SUSPECTED KIDNEY STONE=== | ===5.18 SUSPECTED KIDNEY STONE=== | ||
[[Initial Medical Assessment and Care|INITIAL MEDICAL CARE]] (2.01) - Provide [[ | [[Initial Medical Assessment and Care|INITIAL MEDICAL CARE]] (2.01) - Provide [[Oxygen|OXYGEN]] or assist ventilations as appropriate for patient condition. Use vomiting precautions. | ||
* If age >50, consider Abdominal Aortic Aneurysm etiology | * If age >50, consider Abdominal Aortic Aneurysm etiology | ||
* If hypotension / shock are present, refer to [[Shock|SHOCK PRACTICE PARAMETER]] (5.13). | * If hypotension / shock are present, refer to [[Shock|SHOCK PRACTICE PARAMETER]] (5.13). | ||
* For patients with severe vomiting, obtain detailed history, and then administer [[ | * For patients with severe vomiting, obtain detailed history, and then administer [[Zofran|ZOFRAN (ONDANSETRON HYDROCHLORIDE)]]: | ||
** Adult: 4mg slow IVP. (Consider diluting in 10-20cc to aid in administering slowly) or 4mg/2ml deep IM in a large muscle. | ** Adult: 4mg slow IVP. (Consider diluting in 10-20cc to aid in administering slowly) or 4mg/2ml deep IM in a large muscle. | ||
** Pediatric : Refer to Handtevy System | ** Pediatric : Refer to Handtevy System | ||
| Line 15: | Line 15: | ||
'''''If PROPERLY hydrated and no suspected dehydration, consider administration of: [[ | '''''If PROPERLY hydrated and no suspected dehydration, consider administration of: [[Toradol|TORADOL (KETOLORAC)]] 30mg slow IVP''''' | ||
'''''For Pain Management: Refer to [[Analgesia and Sedation|ANALGESIA/SEDATION PRACTICE PARAMETERS]] (2.04) [[ | '''''For Pain Management: Refer to [[Analgesia and Sedation|ANALGESIA/SEDATION PRACTICE PARAMETERS]] (2.04) [[Morphine_Sulfate|MORPHINE]] 2-20 mg (IV,IO, IN, IM), titrated to effect''''' | ||
If patient presents with: | If patient presents with: | ||
| Line 25: | Line 25: | ||
* Current renal impairment | * Current renal impairment | ||
Fluid Bolus, 200-300cc NS followed by [[ | Fluid Bolus, 200-300cc NS followed by [[Toradol|TORADOL (KETOROLAC)]] 15mg slow IVP. Administer nothing by mouth. | ||
[[Category:Medical|0518]] | |||
Latest revision as of 14:31, 24 April 2020
Section 5 -MEDICAL
5.18 SUSPECTED KIDNEY STONE
INITIAL MEDICAL CARE (2.01) - Provide OXYGEN or assist ventilations as appropriate for patient condition. Use vomiting precautions.
- If age >50, consider Abdominal Aortic Aneurysm etiology
- If hypotension / shock are present, refer to SHOCK PRACTICE PARAMETER (5.13).
- For patients with severe vomiting, obtain detailed history, and then administer ZOFRAN (ONDANSETRON HYDROCHLORIDE):
- Adult: 4mg slow IVP. (Consider diluting in 10-20cc to aid in administering slowly) or 4mg/2ml deep IM in a large muscle.
- Pediatric : Refer to Handtevy System
- Obtain detailed history as to hydration status:
- Dry mucous membranes, tongue
- Sunken eyes
- Urine output
- Multiple episodes of vomiting or diarrhea
If PROPERLY hydrated and no suspected dehydration, consider administration of: TORADOL (KETOLORAC) 30mg slow IVP
For Pain Management: Refer to ANALGESIA/SEDATION PRACTICE PARAMETERS (2.04) MORPHINE 2-20 mg (IV,IO, IN, IM), titrated to effect
If patient presents with:
- Possible dehydration
- History of renal impairment
- Current renal impairment
Fluid Bolus, 200-300cc NS followed by TORADOL (KETOROLAC) 15mg slow IVP. Administer nothing by mouth.